Skin Erythema
Skin Erythema - Related Videos
06:24
Minimal Erythema Dose (MED) Testing
0 Views •
Cited by 70 •
2013
This article describes how to conduct minimal erythema dose (MED) testing in order to determine the lowest dose of ultraviolet radiation that will cause erythema (burning) when administered to an individual.
07:59
Murine Full-thickness Skin Transplantation
0 Views •
Cited by 41 •
2017
Murine full-thickness skin transplantation is a well-established model to study rejection in an alloimmune setting. Here, we provide a tutorial of each step involved in performing a BALB/c-->C57BL/6 full-thickness skin transplant.
12:23
Granulocyte-dependent Autoantibody-induced Skin Blistering
0 Views •
2012
In the animal model described in our present work, purified IgG antibodies against a stretch of 200 amino acids (aa 757-967) of collagen VII are injected repeatedly into mice reproducing the blistering phenotype as well as the histo- and immunopathological features characteristic to human epidermolysis bullosa acquisita (EBA)1.
05:44
Skin Biopsy for Diagnosing Discoid Lupus Erythematosus
0 Views •
Cited by 2 •
2025
Skin lesions are common and important features in many rheumatic diseases, and biopsy with pathological analysis plays a critical role in diagnosis. This article provides a detailed overview of the standardized skin biopsy procedure and, using discoid lupus erythematosus as an example, highlights the essential role of dermatopathology in diagnosing rheumatic diseases.
09:42
Development of an Economical DNA Delivery System by "Acufection" and its Application to Skin Research
0 Views •
2017
This protocol is a cost-effective alternative for expressing naked plasmid DNA in mouse skin. The overall goal of the protocol is to deliver immune-related genes into skin tissue to delineate the functional role of a specific gene in cutaneous inflammation.
FAQs
Local mediators influence Skin Erythema by changing vascular tone in superficial dermal vessels. This vascular adjustment increases blood flow near the surface, making the response visibly detectable. Because the mediators act locally, the observed change can be interpreted in relation to a nearby irritant, inflammatory process, or tissue injury.
Intensity and duration provide complementary information about a cutaneous response. The visible change may vary in how pronounced it appears and how long it persists, so recording only one feature can limit interpretation. Considering both dimensions helps researchers describe treatment-related skin effects more consistently and evaluate changes over time.
Skin Erythema can occur in several biological contexts, including irritation, inflammation, and tissue injury. Its visible appearance alone does not identify which context is responsible, so researchers interpret the finding alongside the treatment or exposure being studied. This distinction is important when characterizing cutaneous responses rather than treating redness as a single specific outcome.
Cancer researchers can assess Skin Erythema through careful visual examination or instrument-based measurement. The essential goal is consistent monitoring of the skin response, including its onset and severity. Standardized assessment supports clearer comparisons across observations and improves interpretation of treatment-related toxicity, safety, and tolerability.
Monitoring erythema helps characterize cutaneous toxicity associated with radiation therapy, topical agents, and other treatments. Researchers can follow when the response appears and how severe it becomes, using those observations to evaluate skin effects during treatment. This information contributes to broader judgments about therapeutic safety and tolerability.
Consistent monitoring makes visible skin responses more useful for evaluating cancer treatments. Recording erythema systematically helps researchers interpret whether a therapy is producing cutaneous effects and assess the severity of those effects. Visual or instrument-based approaches can support this process, improving the reliability of safety and tolerability assessments.